4-Bromobenzo[b]thiophene CAS 5118-13-8 Puritas >97.0% (GC) Brexpiprazole Intermedia Manufacturer

Description:

Nomen chemicum: 4-Bromobenzo[b]thiophene

CAS: 5118-13-8

Puritas: >97.0% (GC)

Aspectus: Lumen Yellow solidus pulveris

Medium Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Brexpiprazole Intermedia
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazinum Hydrochloridum CAS 913614-18-3
7-(4-Chlorobutoxy) quinolin-2(1H)-one CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Nomen chemicum	4-Bromobenzo[b]thiophene
Synonyma	4-Bromobenzothiophene;4-Bromo-Benzo[b]thiophene;4-Bromo-1-Benzothiophene
CAS Number	5118-13-8
CATTUS Number	RF-PI1103
Stock Status	In Stock, Capacitas 30MT/Annus
Formulae hypotheticae	C8H5BrS
M. Pondus	213.09
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Solidus lux Yellow pulveris
Puritas / Analysis Methodus	>97.0% (GC)
Infrared Imaginis	Conformat ut Structure
NMR	Conformat ut Structure
Test Standard	Enterprise Standard
Consuetudinem	Medium Brexpiprazole (CAS: 913611-97-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

4-Bromobenzo[b]thiophene (CAS: 5118-13-8) media synthetica utilis adhibetur et maxime emitur in Indiam, Americam Septentrionalem, Coream, Iaponicam, Europam.4-Bromobenzo[b]thiophene medius est Brexpiprazolis (CAS: 913611-97-9).Brexpiprazole probatus est ab US Cibus et Drug Administration (FDA) die X mensis Iulii, anno MMXV, ad schizophreniam tractandam et adiunctivam curationem pro tristitia.Brexpiprazole ordinatum est ad meliorem efficaciam et tolerabilitatem praebere (eg, minus akathisia, inquietudine et/vel insomnia) in curationibus adiunctivis institutis ad maiorem inordinationem depressivam (MDD).Brexpiprazole, sub nomine Rexulti notam venditam inter alios, est atypica antipsychotica.Brexpiprazole est receptaculum dopamine D2 agonist partialis et descriptum "serotonin-dopamine modulatoris" (SDAM).Brexpiprazole ab Otsuka et Lundbeck evoluta est, ac successor Otsuka-venditionis atypicae antipsychoticae aripiprazolae (Abilify).